GC7 enhances cisplatin sensitivity via STAT3 signaling pathway inhibition and eIF5A2 inactivation in mesenchymal phenotype oral cancer cells. [electronic resource]
Producer: 20180830Description: 1283-1291 p. digitalISSN:- 1791-2431
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Biomarkers, Tumor
- Cell Proliferation -- drug effects
- Cisplatin -- pharmacology
- Drug Synergism
- Epithelial-Mesenchymal Transition -- drug effects
- Guanine -- analogs & derivatives
- Humans
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Mouth Neoplasms -- drug therapy
- Peptide Initiation Factors -- antagonists & inhibitors
- RNA-Binding Proteins -- antagonists & inhibitors
- STAT3 Transcription Factor -- antagonists & inhibitors
- Signal Transduction
- Tumor Cells, Cultured
- Xenograft Model Antitumor Assays
- Eukaryotic Translation Initiation Factor 5A
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.